Kura Oncology (KURA) Enterprise Value: 2024-2025
Historic Enterprise Value for Kura Oncology (KURA) over the last 2 years, with Sep 2025 value amounting to $218.5 million.
- Kura Oncology's Enterprise Value fell 79.03% to $218.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.8 billion, marking a year-over-year decrease of 220.06%. This contributed to the annual value of -$50.1 million for FY2024, which is 104.69% down from last year.
- Per Kura Oncology's latest filing, its Enterprise Value stood at $218.5 million for Q3 2025, which was up 266.54% from -$131.2 million recorded in Q2 2025.
- Over the past 5 years, Kura Oncology's Enterprise Value peaked at $1.1 billion during Q1 2024, and registered a low of -$131.2 million during Q2 2025.
- Moreover, its 2-year median value for Enterprise Value was $218.5 million (2025), whereas its average is $446.9 million.
- Data for Kura Oncology's Enterprise Value shows a maximum YoY plummeted of 112.18% (in 2025) over the last 5 years.
- Kura Oncology's Enterprise Value (Quarterly) stood at -$50.1 million in 2024, then crashed by 79.03% to $218.5 million in 2025.
- Its Enterprise Value stands at $218.5 million for Q3 2025, versus -$131.2 million for Q2 2025 and -$125.2 million for Q1 2025.